Addus HomeCare's stock plummeted 5.61% during intraday trading on Tuesday, following negative analyst actions that weighed on investor sentiment.
The decline came after Barclays maintained its Sell rating on the company with a price target of $102.00. Additionally, Bofa Global Research cut its price objective for Addus HomeCare to $140.00 from $147.00, contributing to the downward pressure on the stock.